EUR/USD

The term “rate cut” is effectively banished in central bank circles right now. Rumour has it that any mention of The Policy Change That Must Not Be Named at the European Central Bank gets you turned into a frog. Or worse, sent for mandatory training at the German Bundesbank, where someone lectures you about the “1970s” for several hours… Best not mention it ...

The dollar has benefited from a series of stronger-than-expected US economic releases over recent weeks. Most notably, the latest US labour market report showed job creation comfortably exceeding expectations. In addition, the Federal Reserve delivered a more hawkish message than markets had anticipated at its June meeting. Particular attention was paid to ...

NEW: President Trump told NBC News in a phone call he spoke with Israel earlier today and asked them to agree to a ceasefire w/Hezbollah. "It's a positive," he said. "It's a little icing on the cake." He declined to specify whether he had talked to PM Netanyahu directly.

* #ECB CHIEF ECONOMIST LANE SPEAKS IN PARIS - BBG *LANE: ENOUGH COST RISES IN PIPELINE TO KEEP INFLATION ABOVE 3% *ECB'S LANE: HARD TO MAKE CASE THAT WE SHOULDN'T HAVE HIKED *ECB'S LANE: TAKING OUR TIME ON RATES MADE SENSE *ECB'S LANE: EURO-ZONE ECONOMY HAS STEADY MOMENTUM

The producer prices of industrial products were 2.2% higher in May 2026 than in May 2025. A larger year-on-year increase was last recorded in May 2023 (+2.5% on May 2022). The Federal Statistical Office (Destatis) also reports that producer prices in May 2026 were up 0.3% on April 2026.The increase in producer prices compared with the same month of the ...

Torsten Slok, Apollo Global chief economist, joins 'Power Lunch' to discuss the latest Federal Reserve meeting, the stronger signal for the central bank and much more.

The Office of the United States Trade Representative and Mexico’s Secretariat of Economy held the second round of bilateral negotiations related to the Joint Review of the United States-Mexico-Canada Agreement (USMCA) on June 15-17, 2026, in Washington, D.C. In addition, today U.S. Trade Representative Jamieson Greer and Mexican Secretary of Economy Marcelo ...

*US STARTS SECTION 301 PROBE OF GERMANY OVER PHARMACEUTICALS USTR Announces Initiation of Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products Today, U.S. Trade Representative Jamieson Greer initiated an investigation under Section 301 of the Trade Act of 1974 against Germany. This investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory and burdens or restricts U.S. commerce. This investigation follows months of meaningful discussions with our German partners in an effort to resolve this issue. “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,” said Ambassador Greer. “I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals. This is a serious step backwards at a time when our trading partners need to step up and start paying their fair share to fund innovative pharmaceutical research and development. We believe that the United States and Germany can find a path forward that expands access to the most innovative drugs for the German people while ensuring fair reimbursement for the pharmaceuticals made by American workers." “On April 2, 2026, the United States and the United Kingdom announced a ground-breaking arrangement on pharmaceutical pricing that will help drive investment and innovation in both countries. Germany should follow suit with constructive negotiations to address this imbalance.” “Fighting the war against disease is a shared burden across wealthy nations,” said U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. “The United States is calling on Germany to pay its fair share for the innovative treatments its people use. I commend Ambassador Greer for his leadership in confronting this imbalance. Fair reimbursement strengthens medical innovation and helps ensure the development of the next generation of lifesaving cures.”

Prime Minister Mark Carney appears untroubled by U.S. President Donald Trump’s recent claim that the United States would “do better without” the North American free trade pact. Carney says it’s “no secret” Trump “isn’t the biggest fan” of free trade deals, but that doesn’t mean the two countries can’t make progress on trade issues. Trump made the comments ...

Trump: Oil is dropping like a rock